Results 181 to 190 of about 276,512 (289)
Factors Associated with the Anamnestic Immune Response Following Hepatitis B Booster Vaccination in the Elderly. [PDF]
Wang C, Zou Y, Wang X, Liu N.
europepmc +1 more source
ABSTRACT Background Hepatitis B virus (HBV) infection remains a major occupational hazard for healthcare workers (HCWs), particularly in low‐resource settings. Timely and appropriate post‐exposure prophylaxis (PEP) is essential to prevent HBV transmission following occupational exposure; however, its effective use depends largely on healthcare workers’
Esubalew Muluneh Aligaz +3 more
wiley +1 more source
Fecal extracellular vesicles (fEVs) from DILI patients have a distinct bacterial profile. This study provides evidence that bacterial EVs enter the bloodstream. DILI and MASLD F≥3 fEVs increase the pro‐inflammatory response and hepatocyte steatosis. FEVs from DILI patients enhance the hepatotoxic potential of diclofenac.
Antonio J. Ruiz‐Malagón +16 more
wiley +1 more source
Towards HDV Elimination Through HBV Vaccination: Global Strategies, Challenges, and Policy Gaps. [PDF]
Batbold E +3 more
europepmc +1 more source
Clinical progress note: Hepatitis A virus
Visual Abstract Abstract Despite a decline in hepatitis A virus (HAV) incidence following vaccine introduction, HAV remains a public health concern in the United States. Recent multi‐state outbreaks have demonstrated that HAV can re‐emerge and highlight inequities in vaccine coverage or access, outbreak response, and in those with social or health risk
James M. McCluskey III +2 more
wiley +1 more source
Body Mass Index and Vaccine-induced Immune Responses in Children Living With HIV. [PDF]
Massa JD +4 more
europepmc +1 more source
Overcoming barriers, driving progress: Clinical science at IAS 2025
Abstract Introduction The 13th IAS Conference on HIV Science, held in Kigali, Rwanda (13–17 July 2025), highlighted key advances in clinical research. Presentations focused on sustaining HIV treatment and prevention amid financial constraints, innovations in long‐acting oral antiretrovirals, and the management of comorbidities and co‐infections ...
Ezequiel Cordova +3 more
wiley +1 more source
Why the Birth Dose Matters for Hepatitis B Vaccination. [PDF]
Girotto JE +4 more
europepmc +1 more source
The review provides a comprehensive analysis of microbiome‐mediated oncogenic mechanisms in various cancers, emphasizing the unique therapeutic strategies facilitated by nanotechnology. It aims to fill this gap by systematically reviewing nanotechnology‐driven strategies for microbiome elimination, with a focus on their ability to improve the cold TME ...
Yumei Gan, Yan Zhang, Xia Dong, Feng Lv
wiley +1 more source
Investigation of the Association Between COVID-19 and Hepatitis B Vaccination Among Healthcare Workers: A Cross-Sectional Study in Turkey. [PDF]
Ecin SM, Sandal A.
europepmc +1 more source

